Jon Hindar
Chairman at OLINK HOLDING AB
Net worth: 5 M $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jon Aron Olof Heimer | M | 57 |
Olink Proteomics AB
Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden. | 10 years |
Nicolas Roelofs | M | 66 |
Hytest Oy
Hytest Oy BiotechnologyHealth Technology Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland. | 6 years |
Tommi Markus Unkuri | M | 44 |
Hytest Oy
Hytest Oy BiotechnologyHealth Technology Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland. | 5 years |
Maria Severina | M | - |
Hytest Oy
Hytest Oy BiotechnologyHealth Technology Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland. | 30 years |
Rickard El Tarzi | M | - |
Olink Proteomics AB
Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden. | 5 years |
Peder Qvigstad | M | - |
Summa Equity (NO)
| 4 years |
Solange Bullukian | F | 59 | 3 years | |
Carl Raimond | M | 53 | 4 years | |
Fredrik Netzel | M | 55 | 5 years | |
Johan Lund | M | 67 | 4 years | |
Hannah Jacobsen | F | - |
Summa Equity (NO)
| 9 years |
Mary Reumuth | F | 48 | 2 years | |
Maria Elena Olmos | F | - | - | |
Johan Pietilä Holmner | M | - |
Hytest Oy
Hytest Oy BiotechnologyHealth Technology Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland.
Olink Proteomics AB
Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden. | 5 years |
Samuel Edward Dyer Ampudia | M | - | 30 years | |
Christian Melby | M | 50 |
Summa Equity (NO)
| 8 years |
Marianne Elisabeth Johnsen | F | 61 | 15 years | |
Robert Schueren | M | 62 | 2 years | |
Clemencia Barreto Gonzalez del Riego | F | - | - | |
Linda Ramirez-Eaves | F | 52 | 5 years | |
Nick Roelofs | M | - |
Hytest Oy
Hytest Oy BiotechnologyHealth Technology Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland. | - |
Sundeep Singh | M | - |
Summa Equity (NO)
| 3 years |
Annette Roth | F | - |
Summa Equity (NO)
| 3 years |
Martin Gjølme | M | - |
Summa Equity (NO)
| 4 years |
Joo Siang Ng | M | 64 | - | |
Silje Lambrechts | F | - |
Summa Equity (NO)
| 5 years |
Bruno Rossi | M | - | 1 years | |
Michael Vollset | M | - |
Summa Equity (NO)
| 6 years |
Astrid Evenseth Sørgaard | F | 64 |
LGJ Invest AS
| - |
Sebastian Sunde | M | - |
Summa Equity (NO)
| 4 years |
Juhana Jaakko Matias Rauramo | M | - |
Hytest Group Oy
Hytest Group Oy Miscellaneous Commercial ServicesCommercial Services Hytest Group Oy provides business and management consultancy services. The company is headquartered in Turku, Finland. | 3 years |
Oskar Hjelm | M | 39 | 4 years | |
Ida Grundberg | M | 41 | 5 years | |
Diego Cateriano | M | - | - | |
Gregory Moore | M | 59 | 1 years | |
Anna Maria Marsell | F | 46 | 2 years | |
Francesca Carnesella Figuerola | F | - | - | |
Fred S. Apple | M | - |
Hytest Oy
Hytest Oy BiotechnologyHealth Technology Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland. | 8 years |
Eva Walde | F | 61 |
Olink Proteomics AB
Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden. | - |
Volker Pfahlert | M | 66 |
Hytest Oy
Hytest Oy BiotechnologyHealth Technology Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland. | - |
Sheyla Dyer Coriat | F | - | - | |
José Miguel Tirado Melgar | M | - | 11 years | |
Renato Balarezo | M | - | 12 years | |
Gisle Glück Evensen | M | 48 |
Summa Equity (NO)
| 6 years |
Nathalie Mas | F | - | 16 years | |
Johan Holmner | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Pablo Leonardo Trapunsky Vilar | M | - | - | |
Gustavo Salem | M | 60 | 3 years | |
John A. Cottingham | M | 69 |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 8 years |
Jeffrey A. Swiecki | M | 52 |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 2 years |
Mimi Kristine Berdal | F | 63 | 7 years | |
Gregory Lucier | M | 60 |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 5 years |
Svein Stavelin | M | 67 |
Norwegian University of Science & Technology
| 7 years |
Tina Nova | M | 70 | 1 years | |
Kelli A. Richard | F | 55 |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 3 years |
Solange Glaize | F | 60 | - | |
Trygve Arnesen | M | 66 |
Norwegian University of Science & Technology
| 1 years |
Øyvind Mork | M | 70 |
Norwegian University of Science & Technology
| 4 years |
Helga Nes | F | 68 |
Norwegian University of Science & Technology
| 1 years |
Arne Spetalen | M | - |
Norwegian University of Science & Technology
| 4 years |
Karin Valsaa | F | - |
Norwegian University of Science & Technology
| 4 years |
Walter Hafslo Qvam | M | 71 |
Norwegian University of Science & Technology
| 1 years |
Fredrik Major | M | 74 |
Norwegian University of Science & Technology
| 1 years |
Leif W. Andersen | M | 68 |
Norwegian University of Science & Technology
| 4 years |
Jostein Ueland | M | - |
Norwegian University of Science & Technology
| 5 years |
Daryl Jay Faulkner | M | 75 |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 8 years |
Harald Ånnestad | M | 64 |
Norwegian University of Science & Technology
| 4 years |
Lisa A. Miller | F | - |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 1 years |
Svein Ove Bjørnestad | M | 69 |
Norwegian University of Science & Technology
| 1 years |
Joseph Beechem | M | 66 |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 5 years |
Mindor Alvestad | M | 69 |
Norwegian University of Science & Technology
| 4 years |
Petter Karl Aanonsen | M | - |
Norwegian University of Science & Technology
| 4 years |
Otto Svein Skjåstad | M | 66 |
Norwegian University of Science & Technology
| 4 years |
Per Kristian Bakkerud | M | - |
Norwegian University of Science & Technology
| 4 years |
Johanna Isander | F | 42 | - | |
Joseph Beery | M | 61 |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | - |
David Metzger | M | 54 |
Sunfilm AG
Sunfilm AG SemiconductorsElectronic Technology Sunfilm AG is one of the world's largest manufacturers of silicon-based thin-film modules with a combined capacity of 85 megawatts peak (MWp) at its two German production sites in Grossroehrsdorf and Bitterfeld-Wolfen. The company has an additional 60 MWp of capacity under construction as well. Thin-film is one of the fastest growing segments of the solar PV industry. Sunfilm's innovative technology for tandem junction thin-film silicon solar modules allows a larger part of the solar spectrum to be harvested as compared to amorphous silicon thin-film solar modules, leading to higher module efficiencies. Additionally, the amount of silicon needed to produce these modules is significantly less than for crystalline silicon modules. | - |
Stig Trondvold | M | 71 |
Norwegian University of Science & Technology
| 4 years |
Tore Bjørke | M | - |
Norwegian University of Science & Technology
| 4 years |
John Gabriel Thuestad | M | 64 |
Norwegian University of Science & Technology
| 4 years |
Morten Loktu | M | 64 |
Norwegian University of Science & Technology
| 4 years |
Bjarte Henry Bruheim | M | 68 |
Norwegian University of Science & Technology
| 1 years |
Olav Stokke | M | - |
Norwegian University of Science & Technology
| 1 years |
Marit Liland Sandvold | M | 66 |
Norwegian University of Science & Technology
| 4 years |
Tore H. Halvorsen | M | 70 |
Norwegian University of Science & Technology
| 1 years |
David Onions | M | - |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 5 years |
Herdís Dröfn Fjeldsted | F | 53 | 1 years | |
Paul Grossman | M | 63 |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 1 years |
Svein Richard Brandtzæg | M | 67 |
Norwegian University of Science & Technology
| 1 years |
Terje Lokke-Sorensen | M | 65 |
Norwegian University of Science & Technology
| 4 years |
Tom Røtjer | M | 71 |
Norwegian University of Science & Technology
| 1 years |
Margareth Øvrum | F | 65 |
Norwegian University of Science & Technology
| 1 years |
Malvin Villabø | M | - |
Norwegian University of Science & Technology
| 4 years |
Reg Joseph | M | - |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 4 years |
Thomas Ramdahl | M | 68 |
Norwegian University of Science & Technology
| 1 years |
Jon Inge Erdal | M | - |
Norwegian University of Science & Technology
| 4 years |
John Radak | M | 64 |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 4 years |
Sean George | M | 50 |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 5 years |
Ronald A. Matricaria | M | 81 |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 4 years |
Wynetka Ann Reynolds | M | 86 |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
Norway | 56 | 56.00% |
Sweden | 23 | 23.00% |
United States | 15 | 15.00% |
Finland | 8 | 8.00% |
Germany | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jon Hindar
- Personal Network